Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Touchscreen meets insulin pump in Tandem’s new t:slim.
In time for the beginning of this school year, DC Public Schools (DCPS) took a major step toward providing access to essential care for all its students with diabetes...
In January, the American Heart Association and American Diabetes Association published a statement giving their joint recommendations for the primary prevention of CVD...
You call that an artificial pancreas? The pathway to closed loop system.
Do you ever wonder why there aren’t cheaper “generic” insulin products available? This may soon change as the patents for branded insulin begin to expire. In fact, the...
On June 18, Becton, Dickinson, and Company (BD) announced a new collaboration with JDRF to develop a combined insulin infusion and CGM device. It would eliminate the...
The evolving field of type 1 diabetes and how research should improve to get closer to finding a cure.
Halozyme announced recently that Yale researchers have started a 20-patient artificial pancreas study (which is still recruiting) that will test the ability of...
MannKind’s inhalable ultra-rapid-acting insulin Afrezza has its day at the FDA – find out what it can do for patients and how to speak up!
On September 9, the Diabetes Technology Society (DTS) will hold a meeting in Bethesda, Maryland, to discuss higher standards for blood glucose monitors and strips, with...
We ask ACA expert Dr. Jack Lord all the hard questions on healthcare coverage and reimbursement.
On December 11, Orexigen announced the resubmission of its weight management drug Contrave (naltrexone/bupropion) to the FDA. The company has previously stated that it...
For someone with diabetes, forgetting supplies such as a glucometer or insulin can be a life-threatening risk. HelpAround is a mobile app currently in development that...
Sanofi US has worked with the award-winning actor Elizabeth Perkins to film and produce Strength in Numbers , a compelling 15-minute documentary about people with...
Part 1 of our interview with the Helmsley Charitable Trust’s David Panzirer and T1D Exchange's Dana Ball.
On August 23, the American Association of Clinical Endocrinologists (AACE) announced that it will hold a consensus conference on obesity called “Building an Evidence...
We travel to Oregon to support test strip access for people with diabetes. Find out what transpired!
On January 21, Novo Nordisk announced the launch of the NovoPen Echo in the US. This is the first and only pen device available in the US with half-unit dosing and a...
At the ADA meeting. Biodel, Latitude, and Xeris had notable announcements on their glucagon programs. First, Biodel demonstrated a prototype of its new glucagon rescue...
Kerri reflects on what a cure means to her.

Pages